Xilio Therapeutics, Inc. (XLO) stock
XLONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3080% below fair value
$7.63+0.09 (+1.19%)
Close on Nov 18, 2026Market cap $44.12MP/E –Yield –
Xilio Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Xilio Therapeutics's market cap was $55.73M on Nov 11, 2026, against $39.26M a year earlier. Over the last 5 years it ranged from $10.60M to $322.28M, with a median of $48.92M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $55.73M | +68.0% |
| 2025 | Dec 31, 2025 | $33.18M | -21.0% |
| 2024 | Dec 31, 2024 | $41.98M | +177.3% |
| 2023 | Dec 29, 2023 | $15.14M | -79.5% |
| 2022 | Dec 30, 2022 | $73.72M | +491.5% |
| 2021 | Dec 31, 2021 | $12.46M | – |
See a number that looks wrong?